Scout | Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases

This opportunity is no longer accepting applications.

grant

Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases

This grant opportunity supports the development of vaccine adjuvants that enhance or modify immune responses for use in vaccines against infectious and immune-mediated diseases. The program is focused on improving pre-clinical adjuvant development to increase vaccine efficacy, especially for at-risk groups like children, the elderly, and the immunocompromised. The program allows Fast-Track and…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: August 2, 2024

Open for Submission: August 2, 2024

Application Window Closes: October 18, 2024

Keywords

vaccine adjuvants

autoimmune diseases

allergic diseases

immune response

pre-clinical development

vaccine efficacy

immune-mediated diseases

immunotherapy

antigen-specific immune response

intellectual property

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers